Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $1,155,293 (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 28.3%

Value ($000) $326,570 Shares 14,040,000 Est. Cost $21.05 Unrealized +24.9%

GILD GILEAD SCIENCES INC 18.2%

Value ($000) $209,792 Shares 2,889,300 Est. Cost $53.90 Unrealized +9.1%

IRWD IRONWOOD PHARMACEUTICALS INC 16.5%

Value ($000) $191,107 Shares 16,390,000 Est. Cost $11.52 Unrealized +6.5%

BIIB BIOGEN INC 13.4%

Value ($000) $154,269 Shares 643,000 Est. Cost $278.12 Unrealized -7.5%

INVA INNOVIVA INC 9.9%

Value ($000) $114,092 Shares 6,614,000 Est. Cost $13.07 Unrealized +30.4%

— AMARIN CORP PLC 5.6%

Value ($000) $64,873 Shares 19,250,000 Est. Cost $4.13 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 4.8%

Value ($000) $55,948 Shares 4,039,600 Est. Cost $4.84 Unrealized +173.4%

— MERSANA THERAPEUTICS INC 2.3%

Value ($000) $26,742 Shares 4,299,297 Est. Cost $9.56 Unrealized —

— VOR BIOPHARMA INC 0.7%

Value ($000) $8,215 Shares 707,010 Est. Cost $43.10 Unrealized —

— PEAR THERAPEUTICS INC 0.3%

Value ($000) $3,102 Shares 500,356 Est. Cost $6.20 Unrealized —

— REGULUS THERAPEUTICS INC 0.1%

Value ($000) $583 Shares 1,851,851 Est. Cost $1.25 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	14,040,000	$326,570	28.3%	$21.05	+24.9%	SHS	G01767105
GILD	GILEAD SCIENCES INC	2,889,300	$209,792	18.2%	$53.90	+9.1%	COM	375558103
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$191,107	16.5%	$11.52	+6.5%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$154,269	13.4%	$278.12	-7.5%	COM	09062X103
INVA	INNOVIVA INC	6,614,000	$114,092	9.9%	$13.07	+30.4%	COM	45781M101
—	AMARIN CORP PLC	19,250,000	$64,873	5.6%	$4.13	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	4,039,600	$55,948	4.8%	$4.84	+173.4%	COM	09058V103
—	MERSANA THERAPEUTICS INC	4,299,297	$26,742	2.3%	$9.56	—	COM	59045L106
—	VOR BIOPHARMA INC	707,010	$8,215	0.7%	$43.10	—	COM	929033108
—	PEAR THERAPEUTICS INC	500,356	$3,102	0.3%	$6.20	—	CLASS A COM	704723105
—	REGULUS THERAPEUTICS INC	1,851,851	$583	0.1%	$1.25	—	COM NEW	75915K200